Abstract
Thirty secnidazole derivatives have been synthesized and evaluated for Helicobacter pylori (H. Pylori) urease inhibitory activities and anti-inflammatory activities. All of them were reported for the first time. Their chemical structures were characterized by 1H NMR, 13C NMR, MS, and elemental analysis. Compound 5a, 6c and 8c showed the most potent urease inhibitory activities and anti-inflammatory activities with IC50 values of 1.7 μM, 1.0 μM, 2.0 μM and inhibition of 62.60%, 59.54%, 71.76%, respectively. Docking simulation was performed to position compound 6c into the urease active site to determine the probable binding model. Compound 5a, 6c and 8c with potent inhibitory activity against H. pylori may be potential antibacterial agents.
Keywords: Urease inhibitors, Helicobacter pylori, secnidazole derivatives, salicyclic acid derivatives, anti-inflammatory activites, docking, antibacterial agent, urea hydrolase, gastroduodenal diseases, living organisms
Current Bioactive Compounds
Title: The Synthesis, Structure and Activity Evaluation of Secnidazole Derivatives as Helicobacter pylori Urease Inhibitors
Volume: 7 Issue: 4
Author(s): Xi-Shou Huang, Kai Liu, Yong Yin, Wan-Mei Li, Wei Ran, Man Duan, Li-Sheng Wang and Hai-Liang Zhu
Affiliation:
Keywords: Urease inhibitors, Helicobacter pylori, secnidazole derivatives, salicyclic acid derivatives, anti-inflammatory activites, docking, antibacterial agent, urea hydrolase, gastroduodenal diseases, living organisms
Abstract: Thirty secnidazole derivatives have been synthesized and evaluated for Helicobacter pylori (H. Pylori) urease inhibitory activities and anti-inflammatory activities. All of them were reported for the first time. Their chemical structures were characterized by 1H NMR, 13C NMR, MS, and elemental analysis. Compound 5a, 6c and 8c showed the most potent urease inhibitory activities and anti-inflammatory activities with IC50 values of 1.7 μM, 1.0 μM, 2.0 μM and inhibition of 62.60%, 59.54%, 71.76%, respectively. Docking simulation was performed to position compound 6c into the urease active site to determine the probable binding model. Compound 5a, 6c and 8c with potent inhibitory activity against H. pylori may be potential antibacterial agents.
Export Options
About this article
Cite this article as:
Huang Xi-Shou, Liu Kai, Yin Yong, Li Wan-Mei, Ran Wei, Duan Man, Wang Li-Sheng and Zhu Hai-Liang, The Synthesis, Structure and Activity Evaluation of Secnidazole Derivatives as Helicobacter pylori Urease Inhibitors, Current Bioactive Compounds 2011; 7 (4) . https://dx.doi.org/10.2174/157340711798375868
DOI https://dx.doi.org/10.2174/157340711798375868 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Developments and Applications of Derivative Spectrophotometry in Pharmaceutical Analysis
Current Pharmaceutical Analysis Transdermal Oxandrolone: Ex Vivo Percutaneous Absorption Study
Current Drug Delivery The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer
Current Cancer Drug Targets Thalidomide: An Overview of its Pharmacological Mechanisms of Action
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Protein Kinases and Associated Pathways in Pluripotent State and Lineage Differentiation
Current Stem Cell Research & Therapy Editorial (Thematic Issue: Personalized Therapy In Cancer of Digestive System)
Clinical Cancer Drugs Molecular Mechanisms of Biological Activity of Oleanolic Acid - A Source of Inspiration for A New Drugs Design
Mini-Reviews in Organic Chemistry Aurora B Kinase and Passenger Proteins as Targets for Cancer Therapy
Current Enzyme Inhibition Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer
Anti-Cancer Agents in Medicinal Chemistry Anti-Diabetic Compounds and their Patent Information: An Update
Recent Patents on Inflammation & Allergy Drug Discovery Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry A Comprehensive Review of the Genus Pyrola Herbs in Traditional Uses, Phytochemistry and Pharmacological Activities
Current Topics in Medicinal Chemistry A Perspective on Clinical Islet Transplantation: Past, Present and Developments for Future
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy
Current Drug Targets MicroRNA Polymorphisms, MicroRNA Pharmacogenomics and Cancer Susceptibility
Current Pharmacogenomics and Personalized Medicine Proteomics Approach to Illustrate Drug Action Mechanisms
Current Drug Discovery Technologies Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications
Current Pharmaceutical Design Inhibitors of Myostatin- and Proteasome-Dependent Signaling for Attenuating Muscle Wasting
Recent Patents on Regenerative Medicine Lysophospholipids: Synthesis and Biological Aspects
Current Organic Chemistry The Discrepancy between Gross Features and Chemical Compositions in Gallbladder Stone: A Descriptive Single Center Study in the United Arab Emirates
New Emirates Medical Journal